Effects of exogenous glucagon on lipids in lipoproteins and liver of lactating dairy cows
- PMID: 14507025
- DOI: 10.3168/jds.S0022-0302(03)73886-7
Effects of exogenous glucagon on lipids in lipoproteins and liver of lactating dairy cows
Abstract
Decreased concentrations of phospholipids, free cholesterol, and cholesteryl ester in plasma and liver are associated with fatty liver, a major metabolic disease of dairy cows in early lactation. The objective was to test whether daily subcutaneous injections of 7.5 and 15 mg of glucagon, which can decrease concentrations of liver triacylglycerol, affect concentrations of plasma lipoprotein components and liver lipids other than triacylglycerol. Multiparous Holstein cows (n = 32) were grouped on the basis of liver triacylglycerol concentrations at d 8 postpartum into "normal" (n = 8; triacylglycerol <1% liver wet wt) and "susceptible to fatty liver" (n = 24; triacylglycerol >1% liver wet wt) cows. Susceptible cows were assigned randomly to three groups and beginning at d 8 postpartum received 0 (same for Normal cows), 2.5, or 5 mg of glucagon by subcutaneous injections every 8 h for 14 d. In comparison to saline injections, subcutaneous injections of glucagon either increased or tended to increase concentrations of phospholipids and free cholesterol in liver, with greater increases of the latter during ambient temperatures below 35 degrees C. Glucagon injections decreased or tended to decrease concentrations of very low-density lipoprotein-triacylglycerol, high-density lipoprotein1-phospholipids, and high-density lipoprotein2-free cholesterol in plasma, with no changes of the latter two during ambient temperatures below 35 degrees C. The results indicate that subcutaneously administered glucagon has only minor effects on the lipid transport in plasma of dairy cows in early lactation with more beneficial effects occurring during ambient temperatures below 35 degrees C and, most importantly, no indications that glucagon has negative effects.
Similar articles
-
Exogenous glucagon effects on health and reproductive performance of lactating dairy cows with mild fatty liver.Anim Reprod Sci. 2007 Dec;102(3-4):194-207. doi: 10.1016/j.anireprosci.2006.11.003. Epub 2006 Nov 28. Anim Reprod Sci. 2007. PMID: 17126505 Clinical Trial.
-
Prevention of fatty liver in transition dairy cows by subcutaneous injections of glucagon.J Dairy Sci. 2006 May;89(5):1533-45. doi: 10.3168/jds.S0022-0302(06)72221-4. J Dairy Sci. 2006. PMID: 16606724 Clinical Trial.
-
Potential treatment of fatty liver with 14-day subcutaneous injections of glucagon.J Dairy Sci. 2003 Oct;86(10):3138-47. doi: 10.3168/jds.S0022-0302(03)73915-0. J Dairy Sci. 2003. PMID: 14594232
-
Time trends of plasma lipids and enzymes synthesizing hepatic triacylglycerol during postpartum development of fatty liver in dairy cows.J Dairy Sci. 1995 Oct;78(10):2208-20. doi: 10.3168/jds.S0022-0302(95)76848-5. J Dairy Sci. 1995. PMID: 8598405
-
Plasma concentration and lipid composition of lipoproteins in lactating dairy cows fed control and high grain diets.J Dairy Sci. 1984 Dec;67(12):2894-901. doi: 10.3168/jds.S0022-0302(84)81652-5. J Dairy Sci. 1984. PMID: 6530488
Cited by
-
Association of Glucagon to Insulin Ratio and Metabolic Syndrome in Patients with Type 2 Diabetes.J Clin Med. 2023 Sep 6;12(18):5806. doi: 10.3390/jcm12185806. J Clin Med. 2023. PMID: 37762748 Free PMC article.
-
Qualitative and Quantitative Changes in Total Lipid Concentration and Lipid Fractions in Liver Tissue of Periparturient German Holstein Dairy Cows of Two Age Groups.Front Vet Sci. 2022 Mar 15;9:814808. doi: 10.3389/fvets.2022.814808. eCollection 2022. Front Vet Sci. 2022. PMID: 35372546 Free PMC article.
-
Integrated Metabolomics and Lipidomics Analysis Reveal Remodeling of Lipid Metabolism and Amino Acid Metabolism in Glucagon Receptor-Deficient Zebrafish.Front Cell Dev Biol. 2021 Jan 14;8:605979. doi: 10.3389/fcell.2020.605979. eCollection 2020. Front Cell Dev Biol. 2021. PMID: 33520988 Free PMC article.
-
Autophagy mediates hepatic GRK2 degradation to facilitate glucagon-induced metabolic adaptation to fasting.FASEB J. 2020 Jan;34(1):399-409. doi: 10.1096/fj.201901444R. Epub 2019 Nov 22. FASEB J. 2020. PMID: 31914606 Free PMC article.
-
Glucagon Receptor Signaling and Lipid Metabolism.Front Physiol. 2019 Apr 24;10:413. doi: 10.3389/fphys.2019.00413. eCollection 2019. Front Physiol. 2019. PMID: 31068828 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources